<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01038791</url>
  </required_header>
  <id_info>
    <org_study_id>593</org_study_id>
    <nct_id>NCT01038791</nct_id>
  </id_info>
  <brief_title>Patients-ventilator Interaction During Sleep: Effect of Humidification System</brief_title>
  <official_title>Patients-ventilator Interaction During Sleep: the Role of Humidification. A Pilot Short Term Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliero-Universitaria di Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliero-Universitaria di Bologna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, little data is available in the medical literature regarding the affects of&#xD;
      humidification on NIMV efficacy, sleep quality and upper airway symptoms in patients&#xD;
      undergoing nocturnal NIMV.&#xD;
&#xD;
      The aim of the present pilot study is to assess the impact of two humidification systems on&#xD;
      sleep quality, NIMV efficacy, patient-ventilator interaction, prevalence of NIMV side&#xD;
      effects, compliance to treatment, in a group of stable patients already enrolled in a&#xD;
      long-term nocturnal mechanical ventilation program for chronic hypercapnic respiratory&#xD;
      failure or sleep hypoventilation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND Non-invasive mechanical ventilation (NIMV), usually delivered during night time,&#xD;
      is widely used at home in chronic hypercapnic respiratory, both in patients with COPD and&#xD;
      restrictive thoracic diseases (RTD). The aim of chronic NIMV is to improve daytime arterial&#xD;
      blood gases, sleep quality decreasing symptoms of hypoventilation (mainly during sleep),&#xD;
      quality of life and mood.&#xD;
&#xD;
      Scarce data is available about the NIMV compliance at home; poor compliance may reduce the&#xD;
      positive effects of mechanical ventilation. Previous data shows that patients enrolled to&#xD;
      long-term home ventilation program may drop out early, mainly because of skin irritation,&#xD;
      upper airway problems, and air leaks.&#xD;
&#xD;
      Studies performed on patients with sleep apnea, receiving CPAP therapy at home, showed that&#xD;
      the occurrence of leaks during ventilation can cause the development of mucosal inflammation,&#xD;
      nasal congestion and increased nasal airways resistance. On the other hand, the presence or&#xD;
      the development of nasal obstruction makes the arise or the worsening of air leaks (the&#xD;
      vicious cycle) more reliable.&#xD;
&#xD;
      A lack of humidification may increase nasal resistance and nasal symptoms and, therefore,&#xD;
      contribute to reduction in compliance. Furthermore, leaks may have significant consequences&#xD;
      on inspiratory and expiratory trigger functions, inducing poor patient-ventilator&#xD;
      interactions. Indeed, the presence of ineffective efforts, the most common phenomenon of bad&#xD;
      patient-ventilation interactions, is very common in patients receiving long term home&#xD;
      ventilation and usually associated with poorer gas exchange during sleep.&#xD;
&#xD;
      At present, little data is available in the medical literature regarding the affects of&#xD;
      humidification on NIMV efficacy, sleep quality and upper airway symptoms in patients&#xD;
      undergoing nocturnal NIMV.&#xD;
&#xD;
      The aim of the present pilot study is to assess the impact of two humidification systems on&#xD;
      sleep quality, NIMV efficacy, patient-ventilator interaction, prevalence of NIMV side&#xD;
      effects, compliance to treatment, in a group of stable patients already enrolled in a&#xD;
      long-term nocturnal mechanical ventilation program for chronic hypercapnic respiratory&#xD;
      failure or sleep hypoventilation.&#xD;
&#xD;
      PATIENTS We plan to enrol 20 patients with chronic respiratory failure or sleep&#xD;
      hypoventilation already included in a long-term home non-invasive ventilation program (at&#xD;
      least 3 months).&#xD;
&#xD;
      Inclusion criteria Patients in stable conditions (no acute exacerbations in the 4 weeks&#xD;
      before enrolment), well adapted to ventilation and without problems with the ventilation&#xD;
      mask.&#xD;
&#xD;
      Exclusions criteria Patients with acute respiratory failure, recent exacerbations, severe&#xD;
      co-morbidities (i.e. hearth failure, recent stroke etc.) Recent upper airways surgery.&#xD;
      Allergic rhinitis, severe nasal stenosis.&#xD;
&#xD;
      STUDY DESIGN&#xD;
&#xD;
      Patients will undergo three consecutive nocturnal polysomnographs. Patients will have a&#xD;
      baseline therapy of NIMV without humidification for 1 week. They will then undergo a&#xD;
      nocturnal polysomnograph on the last evening of the baseline therapy. Patients will then be&#xD;
      randomly assigned to use HH or HME for 1 week and undergo a nocturnal polysomnography on the&#xD;
      last evening . The patients will then be assigned to the second method of humidification for&#xD;
      1 week and undergo a third nocturnal polysomnograph on the last evening. The whole evaluation&#xD;
      will be performed with the same ventilator (ideally the patient's device) using the patient's&#xD;
      mask and with the usual ventilator setting.&#xD;
&#xD;
      Measures&#xD;
&#xD;
      At enrolment:&#xD;
&#xD;
      Lung function test Standard questionnaire about the use and tolerability of NIMV at home&#xD;
      Measure of NIMV compliance at home Blood gas analysis during wakefulness (during spontaneous&#xD;
      breathing - SB - and during NIMV) The breathing pattern during wakefulness (during SB and&#xD;
      NIMV)&#xD;
&#xD;
      Polysomnographic evaluation&#xD;
&#xD;
      Full standard assisted polysomnography with simultaneous recordings of Tidal Volume, Leaks,&#xD;
      pressure in mask, respiratory rate, instantaneous minute ventilation.&#xD;
&#xD;
      Analysis of sleep data will be performed according to standard criteria (AASM 2007).&#xD;
&#xD;
      Analysis of breathing pattern and patients-ventilator interaction will be made according to&#xD;
      previous published methods (Fanfulla, Tuggey, Techsler etc..).&#xD;
&#xD;
      At the end of the each PSG recording, patients will be asked about their humidification and&#xD;
      NIMV tolerance as well as the presence of upper airway symptoms (Nava et al).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sleep quality and asynchrony index</measure>
    <time_frame>8 hrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>tolerance assessed using an ad-hoc designed scale (1 t0 5 scale), and the effective hours of sleep</measure>
    <time_frame>8 hrs</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Chronic Hypercapnic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>usual ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>application of usual mechanical ventilation without humidification system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>heated humidifier</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mechanical ventilation with heated humidifier</description>
  </arm_group>
  <arm_group>
    <arm_group_label>heat and moisture exchanger</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mechanical ventilation with heat and moisture exchanger</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>heated humidification</intervention_name>
    <description>temperature 35Â°</description>
    <arm_group_label>heated humidifier</arm_group_label>
    <other_name>HH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>heat and moisture exchanger</intervention_name>
    <description>single patient device</description>
    <arm_group_label>heat and moisture exchanger</arm_group_label>
    <other_name>HME</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>usual mechanical ventilation without humidification</intervention_name>
    <description>mechanical ventilation with usual parameters</description>
    <arm_group_label>usual ventilation</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in stable conditions (no acute exacerbations in the 4 weeks before&#xD;
             enrolment), well adapted to ventilation and without problems with the ventilation&#xD;
             mask.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with acute respiratory failure, recent exacerbations, severe co-morbidities&#xD;
             (i.e. hearth failure, recent stroke etc.)&#xD;
&#xD;
          -  Recent upper airways surgery.&#xD;
&#xD;
          -  Allergic rhinitis, severe nasal stenosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Fanfulla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione S.Maugeri</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione S.Maugeri</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Nava S, Cirio S, Fanfulla F, Carlucci A, Navarra A, Negri A, Ceriana P. Comparison of two humidification systems for long-term noninvasive mechanical ventilation. Eur Respir J. 2008 Aug;32(2):460-4. doi: 10.1183/09031936.00000208.</citation>
    <PMID>18669787</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>December 16, 2009</study_first_submitted>
  <study_first_submitted_qc>December 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2009</study_first_posted>
  <last_update_submitted>October 8, 2014</last_update_submitted>
  <last_update_submitted_qc>October 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliero-Universitaria di Bologna</investigator_affiliation>
    <investigator_full_name>dr. Stefano Nava</investigator_full_name>
    <investigator_title>Chief ICU</investigator_title>
  </responsible_party>
  <keyword>chronic hypercapnic respiratory failure</keyword>
  <keyword>COPD</keyword>
  <keyword>RTD</keyword>
  <keyword>sleep architecture</keyword>
  <keyword>humidification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

